Home > Healthcare > Pharmaceuticals > Finished Drug Form > physiological saline market
Get a free sample of Physiological Saline Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Physiological Saline Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The expanding population, high prevalence of chronic diseases, technological advancements in medicine, and improved access to healthcare services are some of the factors responsible for increased demand for medical and surgical procedures. As the prevalence of chronic diseases is continuously rising, the demand for surgical procedures and medical interventions to treat and manage such diseases is also increasing. More number of people seek medical attention, undergo diagnostic procedures, or medical interventions leading to the increasing demand for physiological saline. Surgical interventions, ranging from minor procedures to complex operations, often require the use of saline for various purposes before, during, and after surgery. It is used for purposes such as irrigation, wound cleansing, tissue manipulation, and intravenous fluid administration during the procedures. Due to its sterile, isotonic nature, and compatibility with the human body; it is highly preferred across all healthcare settings.
The plastic bottles packaging type segment is expected to observe 6.2% CAGR from 2023-2032 driven by benefits, such as lower shipping costs and reduced risk of breakage during transportation
Global market size for physiological saline was USD 5.3 billion in 2022 and will record USD 9.6 billion by end of 2032 due to the higher prevalence of chronic diseases requiring intravenous therapies, such as cancer, diabetes, and cardiovascular conditions
The hospitals segment is expected to record 6.5% CAGR from 2023-2032 owing to the extensive range of medical procedures performed
U.S. physiological saline industry size was USD 2.3 billion in 2022 and is anticipated to witness considerable growth rate through 2032 owing to the surging demand for healthcare services across the country